熱門資訊> 正文
ASlan Pharmaceuticals宣布计划实施ADS比率变更
2024-06-15 05:00
- ASLAN Pharmaceuticals (NASDAQ:ASLN) on Friday said it plans to change the ratio of the American Depositary Shares to its ordinary shares, par value $0.01 per share, from one ADS representing twenty-five ordinary shares to one ADS representing two hundred ordinary shares.
- The ADSs will continue to be traded on Nasdaq under the symbol “ASLN”.
- ASLN +1.05% after hours to $0.41.
- Source: Press Release
More on ASLAN Pharmaceuticals
- ASLAN Pharmaceuticals announces receipt of Nasdaq notice
- Seeking Alpha’s Quant Rating on ASLAN Pharmaceuticals
- Historical earnings data for ASLAN Pharmaceuticals
- Financial information for ASLAN Pharmaceuticals
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
